Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Metformin And Sitagliptin (A10Bd07) As Part Of A So-Called Open House Model.

Name: Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Metformin And Sitagliptin (A10Bd07) As Part Of A So-Called Open House Model.
Start: 2023-07-19
End: -0001-11-30
Location: AOK - Rhineland-Palatinate/Saarland - The health insurance company

AOK - Rhineland-Palatinate/Saarland - The health insurance company Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Metformin And Sitagliptin (A10Bd07) As Part Of A So-Called Open House Model. in Pharmaceuticals. The tender was released on Jul 19, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Metformin And Sitagliptin (A10Bd07) As Part Of A So-Called Open House Model.

Deadline - login to view

MT reference number - 69057523

Product classification - Pharmaceutical products

Organization Details:

Address - Germany

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 69057523

Document Type - Tender Notices

Notice Details and Documents:

Description - Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredients metformin and sitagliptin (A10BD07) within the period from October 1st, 2022 to September 30th, 2024 with the possibility of concluding a contract at any time (open-house model).

Mt Ref Id - 69057523

Deadline - Nov 30, -0001

View more tenders for

Pharmaceuticals Tenders Pharmaceutical products Tenders Germany Tenders

Similar Tenders :

Most Searched